Advisory Services Network’s Microbot Medical MBOT Stock Holding History

Advisory Services Network’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$820	–	2750
2023 Q4	$820	Buy	+500	New	+$666	﹤0.01%	3571
2021 Q1	–	Sell	-4	Closed	–	–	2286
2020 Q4	$0	Hold	4	–	–	﹤0.01%	3526
2020 Q3	$0	Buy	+4	New	+$28	﹤0.01%	3605
2020 Q2	–	Sell	-4	Closed	–	–	2039
2020 Q1	$0	Hold	4	–	–	﹤0.01%	3183
2019 Q4	$0	Hold	4	–	–	﹤0.01%	3184
2019 Q3	$0	Hold	4	–	–	﹤0.01%	2828
2019 Q2	$0	Hold	4	–	–	﹤0.01%	2872
2019 Q1	$0	Hold	4	–	–	﹤0.01%	2618
2018 Q4	$0	Hold	4	–	–	﹤0.01%	2618
2018 Q3	$0	Buy	4 +1	+33%	+$9	﹤0.01%	2566
2018 Q2	$0	Hold	3	–	–	﹤0.01%	2607
2018 Q1	$0	Hold	3	–	–	﹤0.01%	2668
2017 Q4	$0	Buy	+3	New	+$51	﹤0.01%	2586

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisory Services Network's MBOT Position: Q1 2024 in Review

Advisory Services Network sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 500 shares — an estimated $820 sold.

Advisory Services Network first reported a position in MBOT in Q4 2017 and held it in 13 quarters. The position peaked at $820 in Q4 2023. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.

Advisory Services Network reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
Advisory Services Network sold 500 Microbot Medical shares in Q1 2024, an estimated $820.
Advisory Services Network first reported a position in Microbot Medical in Q4 2017 and held it in 13 quarters.
Advisory Services Network's Microbot Medical position peaked at $820 in Q4 2023.
33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.